These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1966975)

  • 21. Neuroreceptor assay with positron emission tomography: definition of transfer coefficients.
    Gjedde A; Wong DF
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):517-20. PubMed ID: 3038932
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurotransmitter receptor mapping by autoradiography and other methods.
    Kuhar MJ; De Souza EB; Unnerstall JR
    Annu Rev Neurosci; 1986; 9():27-59. PubMed ID: 2423006
    [No Abstract]   [Full Text] [Related]  

  • 23. Current status and future applications of cardiac receptor imaging with positron emission tomography.
    Schäfers M; Riemann B; Levkau B; Wichter T; Schäfers K; Kopka K; Breithardt G; Schober O
    Nucl Med Commun; 2002 Feb; 23(2):113-5. PubMed ID: 11891463
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic imaging of patients with cardiomyopathy.
    Geltman EM
    Circulation; 1991 Sep; 84(3 Suppl):I265-72. PubMed ID: 1884495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac positron tomography: current status and future directions.
    Geltman EM; Roberts R; Sobel BE
    Herz; 1980 Apr; 5(2):107-19. PubMed ID: 6970158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of specific binding of bradykinin and D-Arg [Hyp3, Thi5, D-Tic, Oic8] bradykinin in membranes from rat heart.
    Albus U; Gao X; Greenbaum LM
    Agents Actions Suppl; 1992; 38 ( Pt 3)():73-9. PubMed ID: 1334361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging to distinguish between viable and nonviable myocardium: pathophysiologic basis and importance of positron emission tomography.
    Gropler RJ
    AJR Am J Roentgenol; 1993 Sep; 161(3):497-500. PubMed ID: 8352093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy.
    J Nucl Med; 1991 Jan; 32(1):130-5. PubMed ID: 1988617
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart.
    Wharton J; Morgan K; Rutherford RA; Catravas JD; Chester A; Whitehead BF; De Leval MR; Yacoub MH; Polak JM
    J Pharmacol Exp Ther; 1998 Jan; 284(1):323-36. PubMed ID: 9435195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial positron tomography with manganese-52m.
    Atkins HL; Som P; Fairchild RG; Hui J; Schachner E; Goldman A; Ku T
    Radiology; 1979 Dec; 133(3 Pt 1):769-74. PubMed ID: 315580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Positron emission tomography of the heart].
    Henze E
    Z Kardiol; 1987 May; 76(5):255-8. PubMed ID: 3497494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography in the diagnosis and management of coronary artery disease.
    Bratton NG
    J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visualization of neurotransmitter receptors and their mRNAs in the human brain.
    Palacios JM; Mengod G
    Arzneimittelforschung; 1992 Feb; 42(2A):189-95. PubMed ID: 1316751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo study of receptors for neuromediators with PET.
    Syrota A
    Int J Rad Appl Instrum B; 1986; 13(2):127-34. PubMed ID: 3021687
    [No Abstract]   [Full Text] [Related]  

  • 35. Imaging receptors for drugs in neural tissue.
    Kuhar MJ
    Neuropharmacology; 1987 Jul; 26(7B):911-6. PubMed ID: 2821433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac receptors studied by positron emission tomography.
    Syrota A
    Acta Radiol Suppl; 1990; 374():85-91. PubMed ID: 1966975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo assessment of neurotransmitter system in cardiovascular diseases. Clinical issues.
    Merlet P; Caussin C; Poiseau E; Piot O; Mazière B; Syrota A
    Q J Nucl Med; 1996 Mar; 40(1):108-20. PubMed ID: 8681004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atraumatic approach in myocardial perfusion, metabolism and receptors by positron emission tomography].
    Syrota A
    Arch Mal Coeur Vaiss; 1988 Oct; 81 Spec No():53-9. PubMed ID: 2850773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac applications of positron-emission tomography.
    Beanlands R; Schwaiger M
    Curr Opin Radiol; 1991 Dec; 3(6):817-27. PubMed ID: 1751292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of neurotransmitter receptors by positron emission tomography: focus on the opiate receptor.
    Frost JJ
    NIDA Res Monogr; 1986; 74():15-24. PubMed ID: 2827031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.